A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

636

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2029

Conditions
Locally Advanced Cervical Carcinoma
Interventions
DRUG

AK104

q3w iv

RADIATION

EBRT

45-50.4Gy

RADIATION

BT

≥80Gy

DRUG

cisplatin

qw iv

DRUG

Placebo

q3w iv

Trial Locations (9)

100005

Peking Union Medical College Hospital, Beijing

200032

Fudan University Shanghai Cancer Center, Shanghai

310005

Women's Hospital School Of Medicine Zhejiang University, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

410013

Xiangya Hospital Central South University, Changsha

430079

Hubei Cancer Hospital, Wuhan

550000

Guizhou Cancer Hospital, Guiyang

610041

West China Second University Hospital, Chengdu

Unknown

Hunan cancer hospital, Changsha

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Akeso

INDUSTRY